Leaf extracts of Hedera helix L. are widely used in the treatment of upper respiratory diseases. The saponins α-hederin and hederacoside C are considered to be the main compounds responsible for the biological activity. α-Hederin and hederacoside C were determined in H. helix leaf extracts using a fast, simple and validated HPLC method. An XTerra MS C18 column and mobile phase composed of 10 mM ammonium acetate at pH 8.5 (adjusted with triethylamine) and acetonitrile were used for the chromatography at 1.2 mL min -1 . The column was kept at 30°C. Detection was performed at 220 nm. An approach utilizing a basic pH of the aqueous part of the mobile phase enabled analysis in 5 minutes in isocratic mode. The method was validated and used for the quality control of H. helix leaf ethanolic extracts.
Hedera helix L. (Araliaceae), known as common ivy or English ivy, is an evergreen woody plant found growing worldwide. The drug, which is pharmaceutically and medically important, is produced from the leaves. Common ivy is mostly used in the form of an extract of leaves and rarely as a tea. The triterpenoid saponins hederacoside C (HedC), the main component, and α-hederin (HedA), and the aglycon hederagenin are considered to be the active substances responsible for mucolytic, spasmolytic, bronchodilatory and antibacterial effects [1, 2] . Extracts obtained from the leaves of H. helix are often used in the treatment of upper respiratory diseases and, moreover, leaf extracts are spasmolytic as well as bronchodilatory and antibacterial [2] [3] [4] . Furthermore, the extract is able to improve the respiratory functions of children with chronic bronchial asthma [5, 6] . Ivy leaf extract was confirmed to be an effective and safe treatment of children's cough [7] . Isolated HedA has been reported to be an inhibitor of the β-adrenergic receptor, which could explain both the secretolytic and bronchiolytic effects of ivy extract [2, 8] . HedA revealed strong hemolytic [9, 10] activity and cytotoxicity against various cancer cell lines and tumors in vivo [8] [9] [10] [11] [12] [13] [14] . The content and ratio of both saponins in the available extracts is variable depending on the quality of the drug and, therefore, it should be continuously monitored.
HedC and HedA have been predominantly determined using HPLC with gradient elution [3, [15] [16] [17] [18] . HedC and HedA were determined in H. helix leaf extracts using phosphoric acid as part of the mobile phase; the total analysis time was more than 30 minutes [3, 17] . The content of saponins varied from 0-14.63 mg mL -1 of the sample for HedC, and 0-6.17 mg mL -1 for HedA. The content of saponins is dependent on factors such as the vegetation period and place of origin. The drying method could also influence the quality of the extracts as well [3] . Four saponins from H. helix (including HedC and HedA) were analysed using HPLC-MS/MS. The retention time of the saponins was not less than 15 minutes [15] . Gaillard reported 2.2%, w/w, of HedC and 0.04%, w/w, of HedA in the powdered leaves of common ivy [15] . HedC was determined in cough syrup using gradient elution and phosphoric acid as a part of the mobile phase [16] .
The focus of our work was placed primarily on the development of a reliable and fast HPLC method and on the analysis of various extracts from the Czech Republic and Poland to obtain information about the composition of ivy extracts.
A rapid isocratic HPLC method was used for the evaluation of the levels of hederacoside C and α-hederin in the extracts of common ivy leaves. The content of HedC was found in the range 7.4 to 18.4 mg in 100 g of the extracts of Types A-D (described in experimental part) and the levels of HedA in the range from 0.7 to 2.3 mg in 100 g of the sample, respectively. The results show differences not only among various types of ivy leaf extracts, but also among batches of one particular extract.
Considering the popularity of ivy preparations, the process of producing standardized extracts should be taken into account. The daily dose of the cough syrup, calculated as the content of HedC and HedA, should be controlled and unified as well, considering the cytotoxic and hemolytic effects of HedA.
Experimental
Sample preparation: Ten mg of ivy leaves extract was accurately weighed, added to 90% MeOH in water to a volume of 10.00 mL, and placed for 15 min in an ultrasonic bath. The sample was filtered through a 0.45 µm filter and analyzed using HPLC.
The reference standard solution for the analysis was prepared in a 100. at 30°C, and detection was performed at 220 nm. A standard calibration curve was used for the assay of both analytes.
Method optimization:
Hydrolysis of HedA leads to hederagenin with a carboxy group, arabinose and rhamnose. The pKa was predicted to be 4.63 [19] . HedC is a bidesmoside, the pKa of which was predicted to be 12.50 [19] .
Mobile phases containing either acetonitrile or methanol and water at different pHs and in different volume ratios were tested for the analysis. The analytical column XTerra MS C18 with a hybridbased, reversed-phase C18 stationary phase was employed for the analysis. The pH of the aqueous part of the tested mobile phase seemed to be the critical parameter during the method development. The pH value was modified using acetic acid, ammonia, ammonium acetate and/or triethylamine (pH in the range 2-9). HedC was retained independently of the pH value compared with the retention of HedA, which was strongly pH dependent and increased with decreasing pH. We chose basic conditions to analyze HedA in a more charged form and to achieve a decreased retention. Under the selected conditions, both analytes were efficiently separated in 5 min.
Method validation:
Method validation was performed to demonstrate the suitability of the method for its intended use. The validation was performed according to the European Pharmacopoeia and ICH guideline requirements [18, 20] and included the characteristics: system suitability test (SST) and method validation. The standard solution was injected 8 times to calculate the SST parameters. Tailing factor, number of theoretical plates, resolution, relative standard deviations (% RSD) of retention times and area were included. The results of the method validation are summarized in Table 1 . The precision was verified on ivy extracts using the sample preparation procedure for each type of extract individually. The samples were prepared 6 times each and analyzed using HPLC. The obtained areas were recalculated to the same sample amount, and relative standard deviations (% RSD) were evaluated. The values of method precision were found to be in the range from 1.64 to 2.87% for HedC and from 2.45 to 4.85% for HedA, respectively. The method accuracy was evaluated by average values of relative standard deviation (% RSD) and as a method recovery using spiked samples of each type of investigated extract at 3 concentration levels, injecting 6 different samples, at each concentration level individually (HedC at 0.2, 0.4 and 0.8. mg per sample and HedA at 0.02, 0.04 and 0.08 mg per sample, respectively). The values of recoveries were found in the range from 97.1 to 101.2% for HedC and from 98.4 to 103.4% for HedA, respectively. The standard calibration curves were evaluated using 6 calibration levels. The linearity was investigated in the range from 5 to 500 mg L for HedC and from 1 to 100 mg L for HedA. The mean regression equations were calculated to be A = (600.8±6.1)x + (30.1±0.03) and A = (163.5±1.8)x -(77.4±0.8) for HedC and HedA, where A is the absorbance and x is the concentration of HedC and HedA. Correlation coefficients were > 0.999 for both analytes. The method sensitivity was measured using limit of detection (LOD) and limit of quantitation (LOQ). The parameters were calculated by means of the signal-to-noise ratio.
Determination of HedC and HedA in extracts of common ivy leaf:
The new validated HPLC method was applied to the determination of HedA and HedC in 4 different dry extracts from common ivy, each sample from 3 different batches, obtained from producers on the local market in the Czech Republic and Poland. These extracts were further utilized for the preparation of cough syrups for the treatment of cough in adults and children. The samples examined in this study are described according to the used extracting medium and drug/extract ratio (DER). Type A and B were prepared using aqueous-ethanolic extraction (extracting medium: ethanol 30%, w/w, DER 5-7.5:1) [4] ; Type C was prepared using as extraction solvent ethanol 50%, v/v: propylene glycol 98:2, v/v (DER 2.2-2.9:1) and Type D was prepared using ethanol 30%, w/w (DER 4-8:1). The requirement for the level of saponins in extracts of common ivy has not yet been set. The European medicines agency [21] established only the minimum content of HedC in dried herbal drug, which is 3.0% [21] . According to the EMA classification, dry ivy leaf extract (DER 4-8:1) is labelled as "well -established use", whereas extract (DER 2.2-2.9:1) was included among the products for "traditional use" (ref. EMA). The results are depicted in Figure  1 and Table 2 .
Figure 1: HPLC analysis of extracts of common ivy leaves
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The content of HedC in the Type A and B extracts was found in the range from 13.9 to 18.4 mg in 100 g of the extract, whereas the level of HedC in Type C extract was in the range from 7.4 to 8.3 mg in 100 g, and in Type D extract from 15.8 to 16.2 mg.
The content of HedA in the Type A and B extracts was found to be in the range from 0.7 to 2.3 mg in 100 g of the extracts, whereas the level of HedA in extract Type C was found in the range from 0.8 to 0.9 mg in 100 g and in the extract Type D in the range from 0.9 to 1.3 mg, respectively.
The content of HedC and HedA differed distinctively among individual batches of one sample type. For example, Type A varied from 13.9 to 18.4 mg of HedC and from 1.1 to 2.3 mg of HedA.
